Ibex Medical Analytics, currently on the DigitalHealth.London Accelerator programme have announced the roll out of the first ever AI-powered diagnostic system for detecting breast cancer in pathology.
Tal Frieman of Ibex, commenting on the news the company has deployed this new diagnostic system for detecting breast cancer, said: “Rolling out this system, while we are on the DigitalHealth.London Accelerator programme is hugely exciting for us. Through the programme we are increasing our understanding of the London NHS and the relevant pathways where our products can support clinicians and ultimately help patients. The access to NHS professionals and experts in the implementation of digital innovations within the NHS in London is a fantastic and unique opportunity for us.”
Sara Nelson, Programme Director of the DigitalHealth.London Accelerator Programme said: “Our Accelerator Programme supports digital innovations we believe best meet the needs of the NHS staff and patients here in London. Ibex are pioneering in artificial intelligence powered cancer diagnostics. DigitalHealth.London is proud to be supporting this innovative company as part of our mission to make London a global capital for digital health.”
For more information visit: ibex-ai.com